Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024. Which stocks will surge next? Unlock AI-picked Stocks
Close

UCB SA (UCB)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
120.35 -1.90    -1.55%
- Delayed Data. Currency in EUR ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 123.40 / 123.50
  • Day's Range: 120.35 - 120.35
Type:  Equity
Market:  Germany
ISIN:  BE0003739530 
S/N:  852738
UCB 120.35 -1.90 -1.55%

UCB Share Price Overview

 
Assess today's live UCB SA (UCB) share price, performance and insights using our live Brussels: UCB stock exchange data.

Analyse the historical data and UCB SA share price performance charts on this page. Our technical summary section provides analysis on UCB share price buy/sell indicators using real-time data (or discuss the UCB (UCB) stock price today with other investors in the UCB EBR share price and sentiment chat forum).

Use the dropdown to select a relevant stock exchange for the current EBR UCB share price (ISIN: BE0003739530) to enhance your trading decisions with our free investment tools and resources.

What Is the UCB SA Share Price Today?
The UCB share price today is 120.35.

What Is the Stock Symbol for UCB SA
The stock symbol (or 'ticker') for UCB SA is "UCB."

What Stock Exchange Does UCB SA Trade On?
UCB SA is listed and trades on the Brussels stock exchange.

Is UCB SA a Good Stock to Buy?
Determining whether UCB SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close122.25
Day's Range120.35 - 120.35
Revenue5.18B
Open120.35
52 wk Range65.68 - 123.2
EPS1.81
VolumeN/A
Market Cap23.41B
Dividend (Yield)0.931 (0.76%)
Average Volume (3m)196
P/E Ratio68.2
Beta0.399
1-Year Change39.65%
Shares Outstanding189,750,583
Next Earnings DateJul 25, 2024
What is your sentiment on UCB?
or
Vote to see community's results!

Technical Summary

Type 5 Min 15 Min Hourly Daily Monthly
Moving Averages Buy Buy Buy Buy Buy
Technical Indicators Strong Buy Strong Buy Strong Buy Strong Buy Strong Buy
Summary Strong Buy Strong Buy Strong Buy Strong Buy Strong Buy

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Belt Hold Bearish 1D Current
Belt Hold Bearish 1W Current
Completed Patterns
Tri-Star Bearish 1H 3 Apr 22, 2024 16:00
Tri-Star Bearish 30 3 Apr 22, 2024 16:00
Tri-Star Bearish 15 3 Apr 22, 2024 16:00

UCB SA Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  Brussels 123.45 0.00 0.00 71,800 +2.19% EUR  
  BATS Europe 118.28 0.00 0.00 0 0.00% EUR  
  OTC Markets 64.67 0.00 0.00 3,006 -0.90% USD  
  London 123.50 121.95 124.60 7,431 +2.08% EUR  
  TradeGate 123.50 123.40 123.50 731 +1.48% EUR  
  Frankfurt 120.35 123.40 123.50 0 -1.55% EUR  
  Vienna 107.55 107.55 108.75 0 +0.00% EUR  

Trending Stocks

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Lloyds Banking 51.04 52.18 50.96 -0.74 -1.43% 46.52M  
  Barclays 202.00 205.45 194.32 +10.86 +5.68% 83.32M 14:29:28  
  Rolls-Royce Holdings 402.38 414.20 401.20 -14.62 -3.51% 12.74M 14:29:27  
  Legal & General 232.07 238.10 231.67 -16.53 -6.65% 15.41M 14:29:30  
  AstraZeneca 11,962.0 12,086.0 11,790.0 +610.0 +5.37% 1.46M 14:29:30  
  HSBC 658.70 663.90 657.70 -4.90 -0.74% 5.47M 14:29:08  
  IAG 175.00 178.30 174.50 -1.95 -1.10% 7.40M 14:29:03  
  Axis Bank GDR 68.20 68.60 67.20 +3.20 +4.92% 29.72K 14:26:25  
  BAE Systems 1,293.50 1,358.00 1,291.50 -70.00 -5.13% 4.32M  
  BP 527.30 529.60 520.00 +1.70 +0.32% 20.57M  

%SHORT_NAME% Company Profile

IndustryPharmaceuticals
SectorHealthcare
Employees

8767

Equity Type

ORD

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company’s primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson’s disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. It also offers Evenity for the treatment of osteoporosis in postmenopausal women; Bimzelx for treating plaque psoriasis, psoriatic arthritis, and axial spondyloarthritis; and Fintepla to treat Dravet syndrome. In addition, the company is involved in developing rozanolixizumab and Zilbrisq to treat myasthenia gravis; dapirolizumab pegol for systemic lupus erythematosus; fenfluramine to treat CDKL5 deficiency disorder; doxecitine for TK2 deficiency disorder; STACCATO alprazolam for stereotypical prolonged seizures; bepranemab to treat Alzheimer’s disease; minzasolmin and UCB0222 for Parkinson’s disease; and UCB1381 and UCB9741 for atropic dermatitis. Further, it engages in contract manufacturing activities. UCB SA has collaboration agreements with Amgen, Biogen, Roche/Genentech, Novartis, and Otsuka. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.

Read More
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

UCB Price Commentary

Write your thoughts about UCB SA
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email